http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12586249

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 818
issn 1179-1942
0114-5916
issueIdentifier 11
pageRange 799-818
publicationName Drug Safety
startingPage 799
bibliographicCitation Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf. 2004;27(11):799–818. doi: 10.2165/00002018-200427110-00004. PMID: 15350152.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e126c233c8512845214dd318be13e2a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ce499a580f3f8fd5d7f69fea425c503
date 200409
identifier https://doi.org/10.2165/00002018-200427110-00004
https://pubmed.ncbi.nlm.nih.gov/15350152
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1481
https://portal.issn.org/resource/ISSN/0114-5916
https://portal.issn.org/resource/ISSN/1179-1942
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title A Benefit-Risk Assessment of Baclofen in Severe Spinal Spasticity
discusses http://id.nlm.nih.gov/mesh/M0002117
http://id.nlm.nih.gov/mesh/M0014240
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001418Q000009
http://id.nlm.nih.gov/mesh/D001418Q000493
http://id.nlm.nih.gov/mesh/D009125Q000009
http://id.nlm.nih.gov/mesh/D009128Q000188
http://id.nlm.nih.gov/mesh/D009128Q000209
http://id.nlm.nih.gov/mesh/D009125Q000493
http://id.nlm.nih.gov/mesh/D009103Q000150
http://id.nlm.nih.gov/mesh/D013119Q000150
http://id.nlm.nih.gov/mesh/D001418Q000627
http://id.nlm.nih.gov/mesh/D009125Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D007278
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D018570
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5487
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6757
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9594
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5378825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2952
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7093
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9271
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11418
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6914273

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128190746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128418030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46508181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683258

Total number of triples: 62.